The Public Nordic Life Science Sector



The Public Nordic Life Science sector is radiply expanding and by the end of 1st Half 2011, the sector consists of 114 companies.


In 2nd Quarter 2011 alone 8 Life Science companies completed an IPO and entered the Nordic stock market.


By the end of 1st Half 2011 the total market value of the sector exceeded mind staggering 130 billion Euro.


The sector is extremely fragmented as these companies are listed on five different Nordic stock exchanges which are: 


  • Nasdaq OMX Nordic (larger Danish, Finnish and Swedish companies)


  • Nasdaq OMX First North (smaller start-up companies based in Denmark, Sweden and Finland)


  • Oslo Bors (established Norwegian Life Science companies)


  • Oslo Axess (smaller Norwegian companies) 


  • AktieTorget (smaller Swedish companies)


As the only research company in the region Nordic Bio Investor is tracking the development in the entire public Nordic Life Science sector. Through a range of detailed market surveys we are keeping our clients up to date with the latest development in this exciting sector, which is set to continue its growth in many years to come.





Become a Client/Subscriber


For new Corporate Clients we are right now offering a free 6-week no commitment trial period which include 3 issues of NBI Insight.


For new Individual Clients we are offering a free 2-week no commitment trial period, which include 1 issue of NBI Insight. 


To sign up for a free trial period please fill in the requested information below: